布里格姆妇女医院和贝斯以色列女执事医疗中心，无论是在波士顿，研究人员已经发现了可用于识别谁可能发展肾癌人的生物标志物。称为肾损伤分子-1（KIM-1），标记通常存在于血液和尿液的低水平。
研究人员测量KIM-1在人在欧洲前瞻性研究癌症和营养录取。They compared levels in 190 participants who developed kidney cancer (also called renal cell carcinoma, or RCC) within five years to those of 190 participants matched for age, body mass index (BMI), smoking status, and other factors who didn’t develop kidney cancer. They found that KIM-1 levels were twice as high in those who developed RCC.
据波士顿研究人员，KIM-1测试双打的用于测量肾脏病的生物标记物，并可能允许早期发现肾癌的电流筛选测试的准确性。
从来源：临床癌症研究